v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 14,337,753 $ 4,078,751 $ 21,535,010 $ 6,025,201
General and administrative 3,906,172 4,326,820 8,468,477 8,532,620
Total operating expenses 18,243,925 8,405,571 30,003,487 14,557,821
Operating loss (18,243,925) (8,405,571) (30,003,487) (14,557,821)
Other (income) expense        
Interest expense 0 450,052 0 886,988
Interest and other income, net (533,090) (961,237) (1,191,333) (1,388,791)
Gain on sale of asset (89,363) 0 (89,363) (1,145,141)
Other expense 0 359 0 1,399
Total other (income) expense, net (622,453) (510,826) (1,280,696) (1,645,545)
Loss before income taxes (17,621,472) (7,894,745) (28,722,791) (12,912,276)
Provision for income taxes 3,400 8,071 5,400 10,071
Net loss $ (17,624,872) $ (7,902,816) $ (28,728,191) $ (12,922,347)
Loss per common share:        
Basic (in dollars per share) $ (0.44) $ (0.20) $ (0.72) $ (0.39)
Diluted (in dollars per share) $ (0.44) $ (0.20) $ (0.72) $ (0.39)
Weighted average shares of common stock outstanding used to compute loss per share:        
Basic (in shares) 39,659,266 38,669,330 39,655,597 33,334,616
Diluted (in shares) 39,659,266 38,669,330 39,655,597 33,334,616

Source